TRINTELLIX
(https://trintellix.com) 📸 Data Snapshot: June 20, 2026Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
There is a total failure in cross-page alignment: the Clinical Data sub-page and the Resources sub-page deliver the exact same high-level summary as the Homepage. While the meta title promises ‘clinical studies and dosing,’ the actual content of the clinical-data URL in this crawl fails to provide more granular detail than the landing page. This creates a significant gap between the navigational promise (Signal) and the delivered data (Substance).
Semantic Coherence is read from the heading hierarchy first: what each page announces in its H1 and headings, then whether the body actually delivers on it. Below is the structure the engine mapped, followed by the clean text to check for drift between promise and reality.
🏗️ Semantic Structure — heading hierarchy & page identity (the promise the page makes)
HOMEPAGE TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
NAV_HEADER_REPEATED_BODY TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com/resources/)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
NAV_HEADER_REPEATED_BODY TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com/request-a-rep/)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
NAV_HEADER_REPEATED_BODY TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com/clinical-data/)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
📝 The Narrative — clean text per page (homepage promise vs. sub-page reality)
HOMEPAGE (https://trintellix.com) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
SUB-PAGE (https://trintellix.com/resources/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
SUB-PAGE (https://trintellix.com/request-a-rep/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
SUB-PAGE (https://trintellix.com/clinical-data/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
This page presents a snapshot of public data from TRINTELLIX, captured on June 20, 2026, to show how machine logic reads Semantic Coherence signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to TRINTELLIX: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://trintellix.com to view the most current version of its content and see directly what this company is about and what it offers.